Abstract
Full text links
Read article at publisher's site: https://doi.org/10.1016/j.rmed.2007.03.009
Read article for free, from open access legal sources, via Unpaywall: http://www.resmedjournal.com/article/S0954611107001321/pdf
References
Articles referenced by this article (29)
Prevalence and economic burden of bronchiectasis
Clinical Pulm Med 2005
Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care.
Thorax, (8):635-642 2000
MED: 10899238
Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, (4):400-407 2004
MED: 15130905
Standards NCCLS. Performance standards for antimicrobial tests (M100-S8). Villanova, PA: National Committee for Clinical Laboratory Standards. p. 18.
Subtyping isolates of Haemophilus influenzae type b by outer-membrane protein profiles.
J Infect Dis, (5):668-676 1981
MED: 6972422
Adaptive immunity to nontypeable Haemophilus influenzae.
Am J Respir Crit Care Med, (4):587-592 2002
MED: 12433671
Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors.
Thorax, (1):15-19 2002
MED: 11809984
Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort.
Chest, (4):955-961 1995
MED: 7555168
Use of selective media in bacteriological investigation of patients with chronic suppurative respiratory infection.
Lancet, (8172):796-797 1980
MED: 6102681
Show 10 more references (10 of 29)
Citations & impact
Impact metrics
Citations of article over time
Article citations
Clinical Impacts of Pseudomonas aeruginosa Isolation in Patients with Bronchiectasis: Findings from KMBARC Registry.
J Clin Med, 13(17):5011, 24 Aug 2024
Cited by: 0 articles | PMID: 39274224 | PMCID: PMC11396479
Lung microbiome: new insights into bronchiectasis' outcome.
Front Cell Infect Microbiol, 14:1405399, 04 Jun 2024
Cited by: 0 articles | PMID: 38895737 | PMCID: PMC11183332
Review Free full text in Europe PMC
Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and airflow obstruction.
BMC Pulm Med, 24(1):49, 23 Jan 2024
Cited by: 1 article | PMID: 38263115 | PMCID: PMC10804611
Microbiology sampling in non-cystic fibrosis bronchiectasis cases from northern Alberta.
PLoS One, 18(7):e0288704, 14 Jul 2023
Cited by: 0 articles | PMID: 37450508
Coexistence of COVID-19, Pseudomonas, and thoracic actinomycosis in a cystic bronchiectasis case.
BMC Infect Dis, 23(1):203, 06 Apr 2023
Cited by: 0 articles | PMID: 37024776 | PMCID: PMC10078035
Go to all (117) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
Ann Am Thorac Soc, 11(4):496-503, 01 May 2014
Cited by: 129 articles | PMID: 24592925
Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance.
Respir Med, 109(6):716-726, 29 Aug 2014
Cited by: 63 articles | PMID: 25200914
Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum.
Respiration, 74(1):19-25, 03 May 2006
Cited by: 22 articles | PMID: 16675894
[Physiopathology of cystic fibrosis and of infections associated to this disease].
Pneumologia, 56(4):202-207, 01 Oct 2007
Cited by: 1 article | PMID: 18320796
Review